Chronic lung sufferers call for an end to stand-off on access to ’life-changing’ drug

Patients with genetic emphysema are calling for an end to the current stand-off on what they say is a life-changing drug.

Chronic lung sufferers call for an end to stand-off on access to ’life-changing’ drug

Patients with genetic emphysema are calling for an end to the current stand-off on what they claim is a life-changing drug.

They will hold a vigil today before the HSE meets with pharmaceutical company CSL Behring to discuss access to Respreeza.

21 patients with the Alpha 1 condition were previously on a clinical trial for the drug, before a row erupted over who should administer it.

Patients say the therapy is still available however the drug company is not funding its infusion after the HSE said it would not grant reimbursement.

The drug faces a lengthy approval period due to its cost.

In September, campaigners said that losing access to the drug meant that some patients "could be dead in six months".

more courts articles

Man (25) in court charged with murdering his father and attempted murder of mother Man (25) in court charged with murdering his father and attempted murder of mother
Man appears in court charged with false imprisonment of woman in van Man appears in court charged with false imprisonment of woman in van
Man in court over alleged false imprisonment of woman Man in court over alleged false imprisonment of woman

More in this section

Pile or group of multi colored and different sizes of colourful foil wrapped chocolate easter eggs in pink, blue, and gold. Larg Young sisters donate hundreds of Easter eggs to children's hospital
Ireland has third highest level of deaths on rural roads in EU  Ireland has third highest level of deaths on rural roads in EU 
Mother and daughters killed in Mayo crash named locally, as husband returns to Ireland 'Their smiles lit up the room': Tributes paid to mother and daughters killed in Mayo crash
War_map
Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited